Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-06-16

Clinical Trial Update: An Innovative Trial Assessing Donor Sex on Recipient Mortality [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating whether donor sex influences recipient mortality in red blood cell transfusion. Status is currently UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Ottawa Hospital Research Institute | Conditions: Red Blood Cell Transfusion | Phase 4 | Status: UNKNOWN